UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 729

Sortiert nach

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1201-1214

2019

Link zum Volltext

Verfügbarkeit prüfen

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

Clinical gastroenterology and hepatology, 2022-12, Vol.20 (12), p.2858-2867.e5

2022

Link zum Volltext

Verfügbarkeit prüfen

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD

Respiratory medicine, 2012-04, Vol.106 (4), p.531-539

2012

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease, 2017-09, Vol.14 (5), p.476-483

2017

Link zum Volltext

Verfügbarkeit prüfen

Actuarial valuations to monitor defined benefit pension funding

British Actuarial Journal, 2020-01, Vol.25, Article e14

O’Brien, Christopher D.

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.362-367.e9

2012

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1658-1675

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Inflammatory bowel diseases, 2021-06, Vol.27 (7), p.994-1007

2021

Link zum Volltext

Verfügbarkeit prüfen

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

American Journal of Physiology: Cell Physiology, 2002-05, Vol.282 (5), p.C1181-C1190

2002

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma : A randomised clinical trial

Drugs (New York, N.Y.), 2006-01, Vol.66 (17), p.2235-2254

2006

Link zum Volltext

Verfügbarkeit prüfen

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

Current medical research and opinion, 2009-06, Vol.25 (6), p.1563-1571

2009

Link zum Volltext

Verfügbarkeit prüfen

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

Clinical therapeutics, 2007-05, Vol.29 (5), p.823-843

2007

Link zum Volltext

Verfügbarkeit prüfen

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Journal of Crohn's and colitis, 2018-11, Vol.12 (10), p.1158-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

American Journal of Physiology: Cell Physiology, 2004-10, Vol.287 (4), p.C1103-C1113

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial

Annals of allergy, asthma, & immunology, 2011-09, Vol.107 (3), p.258-265.e2

2011

Link zum Volltext

Verfügbarkeit prüfen

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

Blood, 2003-04, Vol.101 (7), p.2816-2825

2003

Link zum Volltext

Verfügbarkeit prüfen

A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

Chronic obstructive pulmonary disease, 2012-04, Vol.9 (2), p.111-120

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

The Journal of immunology (1950), 2000-01, Vol.164 (1), p.452-462

2000

Link zum Volltext

Verfügbarkeit prüfen

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma

Pediatrics (Evanston), 2010-09, Vol.126 (3), p.e565

2010

Link zum Volltext

Verfügbarkeit prüfen

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

British Actuarial Journal, 2024-04, Vol.29

O’Brien, Christopher D.

2024

Link zum Volltext

Verfügbarkeit prüfen

Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma

The Journal of asthma, 2012-02, Vol.49 (1), p.70-77

2012

Link zum Volltext

Verfügbarkeit prüfen

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Crohn's & colitis 360, 2020-10, Vol.2 (4), p.otaa063-otaa063

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients

Allergy and asthma proceedings, 2008-09, Vol.29 (5), p.499

2008

Link zum Volltext

Verfügbarkeit prüfen

Intrapatient symptom variability in adults and children with asthma: results of a survey

Advances in therapy, 2005-09, Vol.22 (5), p.488-497

2005

Link zum Volltext

Verfügbarkeit prüfen

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children

Allergy and asthma proceedings, 2010-01, Vol.31 (1), p.26

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(684)
Mit Volltextzugriff
(650)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

Actuarial valuations to monitor defined benefit pension funding

Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma : A randomised clinical trial

Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial

PECAM-1–dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization

A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma

The exercise of discretion on commutation factors in defined benefit schemes: time for change?

Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients

Intrapatient symptom variability in adults and children with asthma: results of a survey

The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children

Suchergebnisse filtern